Skip to main navigation Skip to search Skip to main content

The losartan renal protection study - Rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

  • Barry M. Brenner
  • , Mark E. Cooper
  • , Dick De Zeeuw
  • , Jean Pierre Grunfeld
  • , William F. Keane
  • , Kiyoshi Kurokawa
  • , Janet B. McGill
  • , William E. Mitch
  • , Hans Henrik Parving
  • , Guiseppe Remuzzi
  • , Arthur B. Ribeiro
  • , Mark D. Schluchter
  • , Duane Snavely
  • , Zhongxin Zhang
  • , Roger Simpson
  • , Denise Ramjit
  • , Shahnaz Shahinfar

Research output: Contribution to journal › Article › peer-review

127   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'The losartan renal protection study - Rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science